BORDI, Cesare
 Distribuzione geografica
Continente #
NA - Nord America 1451
EU - Europa 1062
AS - Asia 595
Continente sconosciuto - Info sul continente non disponibili 6
AF - Africa 1
Totale 3115
Nazione #
US - Stati Uniti d'America 1404
CN - Cina 515
UA - Ucraina 285
SE - Svezia 252
FI - Finlandia 246
DE - Germania 149
TR - Turchia 70
GB - Regno Unito 53
IT - Italia 51
CA - Canada 47
BE - Belgio 19
EU - Europa 6
IR - Iran 5
IN - India 4
FR - Francia 3
CH - Svizzera 1
EG - Egitto 1
ES - Italia 1
NL - Olanda 1
RO - Romania 1
SA - Arabia Saudita 1
Totale 3115
Città #
Chandler 355
Jacksonville 315
Beijing 140
Dearborn 138
Ann Arbor 116
Nanjing 83
San Mateo 69
Princeton 68
Izmir 67
Wilmington 45
Toronto 43
Woodbridge 35
Kunming 33
Nanchang 30
Boardman 27
Jinan 25
Shenyang 24
Helsinki 23
Parma 21
Brussels 19
Hebei 19
Hefei 18
Tianjin 18
Jiaxing 15
Changsha 14
Hangzhou 13
Guangzhou 12
Auburn Hills 11
Bremen 10
Des Moines 9
Haikou 9
Chengdu 7
Lanzhou 6
Los Angeles 6
Norwalk 6
Wenzhou 6
Zhengzhou 6
Ningbo 5
Borås 4
Fremont 4
Fuzhou 4
Houston 4
Rio Saliceto 4
Taizhou 4
Andover 3
Baotou 3
Falls Church 3
Kocaeli 3
Ottawa 3
Rockville 3
Düsseldorf 2
Kashan 2
Leawood 2
Sacramento 2
Seattle 2
Shanghai 2
Taiyuan 2
Xian 2
Augusta 1
Bangalore 1
Cairo 1
Changchun 1
Chaoyang 1
Chicago 1
Chongqing 1
Grafing 1
Hanover 1
Harbin 1
Henderson 1
Huzhou 1
London 1
Madrid 1
Medolla 1
Montréal 1
Mumbai 1
Orange 1
Quzhou 1
Stuttgart 1
Timisoara 1
Zanjan 1
Zurich 1
Totale 1947
Nome #
Xq25 and Xq26 identify the common minimal deletion region in malignant gastroenteropancreatic endocrine carcinomas 78
Involvement of HER-2/neu and metastasis-related proteins in the development of ileal neuroendocrine tumors 78
The assessment of malignancy in endocrine tumours of the gastrointestinal tract 75
Classification of gastric endocrine cells at the light and electron microscopical levels 70
ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis 65
Poorly differentiated endocrine carcinoma 62
p27: a potential main inhibitor of cell proliferation in digestive endocrine tumors but not a marker of benign behavior 62
REPEATED ANASTOMOTIC RECURRENCE OF COLORECTAL TUMORS. GENETIC ANALYSIS OF TWO CASES. 62
The ventricular epicardial fat is related to the myocardial mass in normal, ischemic and hypertrophic hearts. 61
Loss of heterozygosity at 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome 59
Effect of chronic hypergastrinemia on human enterochromaffin-like cells: Insights from patients with sporadic gastrinomas 57
Staging of digestive endocrine tumours using helical computed tomography and somatostatin receptor scintigraphy 56
Endocrine tumors of the gastrointestinal system 55
Peanut-like 1 (septin 5) gene expression in normal and neoplastic human endocrine pancreas 55
Genetic alterations in poorly differentiated endocrine carcinomas of the gastrointestinal tract 54
Classification of neuroendocrine tumours 54
Malignancy-associated allelic losses on X chromosome in foregut but not in midgut endocrine tumours 54
Carcinoid tumor associated with vascular malformation as a cause of massive gastric bleeding 54
Biclonality of gastric lymphomas 53
È L’ANGIOGENESI UN FATTORE PROGNOSTICO NEGLI ADENOCARCINOMI DEL COLON-RETTO IN STADIO B DI DUKES? 52
Sporadic colorectal carcinomas with low-level microsatellite instability: a distinct subgroup with specific clinicopathological and molecular features. 52
Pleomorph poorly differentiated endocrine carcinoma of the rectum 51
Presacral carcinoid tumour. Review of the literature and report of a clinically malignant case 50
Heterotopic mesenteric ossification (Intraabdominal myositis ossificans): Report of five cases 50
Aetiology, molecular pathogenesis and genetics 50
Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q. 50
REPEATED ANASTOMOTIC RECURRENCE OF COLORECTAL TUMORS. GENETIC ANALYSIS OF TWO CASES. 50
Multiple endocrine neoplasia type 1 49
Endocrine cell replacement of oxyntic glands in Zollinger-Ellison syndrome: a role for female sex hormones? 49
Non-functioning tumours and microadenomas 48
The antral mucosa as a new site for endocrine tumors in Multiple Endocrine Neoplasia type-1 and Zollinger Ellison syndromes 47
Gastric neuroendocrine neoplasms: tumor clonality and malignancy associated large X-chromosomal deletions 47
Pancreatic endocrine tumours: Introduction 46
Intramucosal cysts in the gastric body of patients with Zollinger-Ellison syndrome 46
Azidothymidine induces apoptosis and inhibits cell growth and telomerase activity of human parathyroid cancer cells in culture 46
Criteria for malignancy in gastrointestinal endocrine tumors 45
Distinct molecular patterns based on proximal and distal sporadic colorectal cancer: arguments for different mechanisms in the tumorigenesis. 44
OC1.09.3 USEFULNESS OF GASTROPANEL FOR SCREENING OF ATROPHIC GASTRITIS IN PATIENTS WITH AUTOIMMUNE THYROID DISEASES 44
Endocrine cell growths in atrophic body gastritis. Critical evaluation of a histological classification. 43
Biological and molecular aspects of gastroenteropancreatic endocrine tumors. 42
Prospective study of the ability of histamine, serotonin or serum chromogranin A levels to identify gastric carcinoids in patients with gastrinomas 42
Mixed exocrine-endocrine carcinomas 41
Different patterns of 11q allelic losses in digestive endocrine tumors 41
Gastrinomas 40
Highlights on biology of endocrine tumours of the gut and pancreas 40
Long-term follow-up in atrophic body gastritis patients: atrophy and intestinal metaplasia are persistent lesions irrespective of Helicobacter pylori infection 39
Mucosal colonization of gastric endocrine tumors mimicking mixed neoplasms 39
AMPULLARY ADENOCARCINOMA IN VON RECKLINGHAUSEN’S DISEASE. CASE REPORT AND LITERATURE REVIEW. 39
Lack of specific association between gastric autoimmunity hallmarks and clinical presentations of atrophic body gastritis 38
Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type I 38
Somatostatin receptor subtypes 2 and 5 are associated with better survival in well-differentiated endocrine carcinomas. 38
Sampling strategies for analysis of enterochromaffin-like (ECL) cell changes in Zollinger-Ellison syndrome 38
Occurrence and risk factors for benign epithelial gastric polyps in atrophic body gastritis on diagnosis and follow-up 37
Multiple endocrine neoplasia (MEN)-associated tumours 37
Long-term clinical outcome of somatostatin analogues for treatment of progressive, metastatic, well-differentiated entero-pancreatic endocrine carcinoma 35
Fluorescent in situ hybridization as a screening test for HER2 amplification in G2 and G3 breast cancers of lobular and ductal histotype and metastases 34
Hypergastrinemia and gastric enterochromaffin-like cells 33
Quantity of AgNORs in gastric endocrine carcinoid tumours as a potential prognostic tool 32
Prognostic factors in gastrointestinal endocrine tumors 32
Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization 31
Role of topoisomerase I and thymidylate synthase expression in sporadic colorectal cancer: Associations with clinicopathological and molecular features 31
PTU-064 Identification of Syne 1 and Foxe 1 Hypermethylation to improve diagnosis and amangement of colorectal neoplasia in Inflammatory Bowel disease 31
Pitfalls in diagnosis: primary mediastinal non-seminomatous germ cell tumour with bone marrow metastasis showing melanoma-like phenotype. 28
The normal endocrine cell of the gut. Changing concepts and new evidences 26
Gene expression profiles of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel markers and therapeutic targets 25
ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin 25
Pancreatic endocrine tumours: evidence for a tumour suppressor pathogenesis and for a tumour suppressor gene on chromosome 17p 24
Involvement of BCL-2 oncoprotein in the development of enterochromaffin-like cell gastric carcinoids 22
Totale 3121
Categoria #
all - tutte 5681
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5681


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201882 0000 00 106 184026
2018/2019232 3682 960 85 2068817
2019/2020973 1281637026 8198 11420 90971472
2020/2021465 465647 634 624 10414695
2021/2022367 112226 137 4864 173146100
2022/2023719 14713555107 114141 200 0000
Totale 3121